Eisai, Ajinomoto Join GI Forces In Japan Growth Quest
This article was originally published in PharmAsia News
Executive Summary
Eisai is to spin out its gastrointestinal business in Japan into a new joint venture with Ajinomoto, creating what the firms say will be the largest specialty operation in this sector in the country.